Cytodyn Inc (CYDY)

[lorbas95]

Emergcy is right, though. Not being able to raise non-dilutive funding during a time in which the market abounds in liquidity raises a lot of questions about Nader's financial and negotiation skills. The fact that CYDY trades on the OCD can only be a partial excuse. A lot of biotechs with much lesser potential have succeeded in securing more favourable funding. That is a fact. (And even if Nader will secure funding in a month or two (or whenever) his performance on the financial side will still be mediocre).

On the other hand, I am extremely grateful that I can buy shares of a company with such a potential and such a mind-blowing science at a bargain. If the problem of funding would have been solved long ago, the SP would have been much higher, obviously. However, I guess the worst thing that could happen is that CYDY is sold for a fraction of what it is actually worth. So, practically no downside and theoretically unlimited upside if the cancer story unfolds. Btw, Thank you for the productive discussions and scientific knowledge displayed on this board and good luck to all!